Connection
David Allen to Cost-Benefit Analysis
This is a "connection" page, showing publications David Allen has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.049 |
|
|
|
-
Allen DL, Samol J, Benjamin S, Verjee S, Tusold A, Murphy MF. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization. Transfus Med. 2004 Dec; 14(6):409-17.
Score: 0.049